PK
Pradeep Kumar Devulapalli
About Pradeep Kumar Devulapalli
Data last updated:
Pradeep Kumar Devulapalli is a Director at Scikem Pharmaceuticals Private Limited (since 2017). The companies operate in Pharma and Financial Services. Scikem Pharmaceuticals Private Limited reported revenue of ₹20.26 Cr (FY 2024). Earlier, Pradeep Kumar Devulapalli was a Director at Citiport Credit Limited (2010–2019) and Director at Maxkem Laboratories Private Limited (from 2018).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 Mar 2017 | 2017 | ₹20.26 Cr (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 28 Sep 2010 | 1995 | ₹1.9 Lakh (FY 2025) | Active | |
| Director | 22 Nov 2018 | 2018 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Pradeep Kumar Devulapalli
| Name | DIN | Company | Designation |
|---|---|---|---|
| Raji Reddy Akiti | 07755234 | Scikem Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pradeep Kumar Devulapalli
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pradeep Kumar Devulapalli
Pradeep Kumar Devulapalli currently holds 1 directorship: Scikem Pharmaceuticals Private Limited (Director, since 16 Mar 2017, revenue ₹20.26 Cr (FY 2024)).
Pradeep Kumar Devulapalli was first appointed on 28 Sep 2010 as Director at Citiport Credit Limited. The most recent appointment on record is 22 Nov 2018 at Maxkem Laboratories Private Limited.
Pradeep Kumar Devulapalli held 2 earlier board appointments: Citiport Credit Limited (Director, 28 Sep 2010 to 20 Jun 2019); Maxkem Laboratories Private Limited (Director, from 22 Nov 2018).
The current boards of Pradeep Kumar Devulapalli's companies include Raji Reddy Akiti (Scikem Pharmaceuticals Private Limited).